cysteine has been researched along with omeprazole in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Morii, M; Takata, H; Takeguchi, N | 1 |
| Nishiwaki, H; Okabe, S; Takeuchi, K | 1 |
| Blakeman, DP; Im, WB; Sachs, G | 1 |
| Abramochkin, G; Haber, JE; Mason, AB; Monk, BC; Perlin, DS; Seto-Young, D | 1 |
| Besancon, M; Hersey, S; Mercier, F; Miller, M; Munson, K; Sachs, G; Shin, JM | 1 |
| Bergman, NA; Fryklund, J; Kühler, TC; Larsson, H; Lee, A; Weilitz, J | 1 |
| Sachs, G; Shin, JM | 1 |
| Forte, JG; Guan, S; Machen, TE; Watson, C; Zhu, L | 1 |
| Eberini, I; Indiveri, C; Tonazzi, A | 1 |
| Castillo-Villanueva, A; de la Mora-de la Mora, I; Enríquez-Flores, S; Figueroa-Salazar, R; García-Torres, I; Gómez-Manzo, S; Gutiérrez-Castrellón, P; Hernández-Alcántara, G; López-Velázquez, G; Marcial-Quino, J; Méndez, ST; Oria-Hernández, J; Reyes-Vivas, H; Torres-Arroyo, A; Vanoye-Carlo, A; Yépez-Mulia, L | 1 |
| Cartee, NMP; Wang, MM | 1 |
| de la Mora-de la Mora, I; de Vos, P; Enríquez-Flores, S; Fernández-Lainez, C; Flores-López, LA; García-Torres, I; Gutiérrez-Castrellón, P; López-Velázquez, G; Matadamas-Martínez, F; Yépez-Mulia, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for cysteine and omeprazole
| Article | Year |
|---|---|
The basis of differentiation of PPIs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Cysteine; Dose-Response Relationship, Drug; Gastric Acid; Gastroesophageal Reflux; Humans; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Rats; Sulfoxides | 2004 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for cysteine and omeprazole
| Article | Year |
|---|---|
Binding site of omeprazole in hog gastric H+,K(+)-ATPase.
Topics: Adenosine Triphosphatases; Animals; Binding Sites; Cell Membrane; Cysteine; H(+)-K(+)-Exchanging ATPase; Molecular Weight; Muscle, Smooth; Omeprazole; Peptide Fragments; Peptide Mapping; Spectrometry, Fluorescence; Stomach; Swine; Trypsin | 1990 |
Effects of topical application of acidified omeprazole on acid secretion and transmucosal potential difference in anesthetized rat stomachs.
Topics: Administration, Cutaneous; Animals; Cimetidine; Cysteine; Electrodes; Gastric Acid; Gastric Mucosa; Histamine; Histamine Antagonists; Hydrogen-Ion Concentration; Male; Omeprazole; Rats; Rats, Inbred Strains; Urethane | 1988 |
Reversal of antisecretory activity of omeprazole by sulfhydryl compounds in isolated rabbit gastric glands.
Topics: Animals; Benzimidazoles; Cyclohexanones; Cysteine; Gastric Acid; Gastric Mucosa; Glutathione; In Vitro Techniques; Male; Omeprazole; Rabbits; Sulfhydryl Compounds | 1985 |
The yeast plasma membrane proton pumping ATPase is a viable antifungal target. I. Effects of the cysteine-modifying reagent omeprazole.
Topics: Candida albicans; Cell Membrane; Cysteine; Enzyme Inhibitors; Glucose; Humans; Hydrogen-Ion Concentration; Kinetics; Mercaptoethanol; Mutation; Omeprazole; Proton Pump Inhibitors; Proton Pumps; Proton-Translocating ATPases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sulfhydryl Reagents | 1995 |
Membrane topology and omeprazole labeling of the gastric H+,K(+)-adenosinetriphosphatase.
Topics: Adenosine Triphosphate; Amino Acid Sequence; Anti-Ulcer Agents; Cysteine; H(+)-K(+)-Exchanging ATPase; Imidazoles; Intracellular Membranes; Membrane Proteins; Molecular Sequence Data; Omeprazole; Protein Conformation; Stomach; Trypsin | 1993 |
Structure-activity relationship of omeprazole and analogues as Helicobacter pylori urease inhibitors.
Topics: Ammonia; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzamides; Binding Sites; Cysteine; Drug Design; Enzyme Inhibitors; Helicobacter pylori; Hydrogen-Ion Concentration; Mercaptoethanol; Mice; Mice, Inbred Strains; Omeprazole; Structure-Activity Relationship; Urease | 1995 |
Reaction of proton pump inhibitors with model peptides results in novel products.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Catalytic Domain; Cysteine; Enzyme Inhibitors; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Lansoprazole; Mass Spectrometry; Molecular Structure; Omeprazole; Pantoprazole; Peptides; Proton Pump Inhibitors; Pyridones; Sulfamerazine | 2013 |
Molecular mechanism of inhibition of the mitochondrial carnitine/acylcarnitine transporter by omeprazole revealed by proteoliposome assay, mutagenesis and bioinformatics.
Topics: Animals; Antiporters; Biological Assay; Biological Transport; Carnitine; Computational Biology; Cysteine; Kinetics; Membrane Transport Proteins; Mitochondria; Molecular Docking Simulation; Mutagenesis, Site-Directed; Mutant Proteins; Omeprazole; Proteolipids; Proton Pump Inhibitors; Rats; Substrate Specificity | 2013 |
Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.
Topics: Albendazole; Antiprotozoal Agents; Axenic Culture; Cysteine; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Escherichia coli; Gene Expression; Giardia lamblia; Humans; Metronidazole; Mutation; Nitro Compounds; Omeprazole; Parasitic Sensitivity Tests; Protozoan Proteins; Recombinant Proteins; Spectrometry, Fluorescence; Thiazoles; Triose-Phosphate Isomerase; Trophozoites | 2014 |
Binding of omeprazole to protein targets identified by monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal, Murine-Derived; Binding Sites; Cysteine; HEK293 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Multiprotein Complexes; Omeprazole; Protein Binding; Proton Pump Inhibitors | 2020 |
Multilevel Approach for the Treatment of Giardiasis by Targeting Arginine Deiminase.
Topics: Animals; Antiprotozoal Agents; Computer Simulation; Cysteine; Drug Evaluation, Preclinical; Drug Repositioning; Giardia lamblia; Giardiasis; Gold Sodium Thiomalate; Humans; Hydrolases; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Thiamine; Trophozoites | 2021 |